Adjuvant Radiation in Aortic Valvuloplasty - ARAVA

This study will examine the effect of external beam radiation therapy in the prevention of restenosis following successful balloon aortic valvuloplasty in severe, symptomatic aortic stenosis...

Date First Received: December 22, 2005

Last Updated: August 2, 2006

Verified by: Medstar Research Institute, August 2006

Clinical Trial Phase: Phase 3 | Start Date: November 2005

Overall Status: Suspended

Estimated Enrollment: 60

Brief Summary

Condition Keyword(s):

This study will examine the effect of external beam radiation therapy in the prevention of restenosis following successful balloon aortic valvuloplasty in severe, symptomatic aortic stenosis.

Study Type: Interventional

Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study

Intervention(s) in this Clinical Trial

  • Procedure: Balloon Aortic Valvuloplasty
  • Procedure: External Beam Radiation

Criteria for Participation in this Clinical Trial

Inclusion Criteria:

  • Severe Aortic Stenosis
  • NYHA Class 2-4 CHF Symptoms
  • Age > 75
  • EuroSCORE > 7
  • Prohibitively High Risk for Aortic Valve Replacement Surgery as Designated by a Cardiac Surgeon

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 75 Years

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Clinical Trial Sponsor Information

Lead Sponsor: Medstar Research Institute

Overall Clinical Trial Officials and Contacts

Ron Waksman, MD Principal Investigator Medstar Research Institute  

Additional Information

Information obtained from ClinicalTrials.gov on July 02, 2009

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00269165

Study ID Number: 2005-187

ClinicalTrials.gov Identifier: NCT00269165

Health Authority: United States: Institutional Review Board

Clinical Trials Authorship and Review

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.